SEC Filings

Form S-3ASR
ARRAY BIOPHARMA INC filed this Form S-3ASR on 09/13/2017
Document Outline
Entire Document (447 KB)
Subdocument 1 - S-3ASR - S-3ASR
Page 1 - As Filed with the Securities and Exchange Commission on September 13, 2017
Page 2 - PROSPECTUS
Page 3 - TABLE OF CONTENTS
Page 4 - ABOUT THIS PROSPECTUS
Page 5 - ABOUT ARRAY BIOPHARMA
Page 6 - USE OF PROCEEDS
Page 7 - Listing
Page 8 - N/A
Page 9 - Limitation of Liability of Directors
Page 10 - Staggered Board
Page 11 - Authorized but Unissued Shares
Page 12 - Dividends and Other Distributions
Page 13 - Conversion of Preferred Stock
Page 14 - Resignation and Removal of Depositary
Page 15 - N/A
Page 16 - Conversion or Exchange Rights
Page 17 - Discharge, Defeasance and Covenant Defeasance
Page 18 - Modification of the Indenture
Page 19 - N/A
Page 20 - Registered Global Securities and Book Entry System
Page 21 - N/A
Page 22 - Concerning the Trustee
Page 23 - Exercise of Warrants
Page 24 - Enforceability of Rights of Holders of Warrants
Page 25 - Issuance in Series
Page 26 - Street Name Holders
Page 27 - Special Considerations For Indirect Holders
Page 28 - Special Situations When A Global Security Will Be Terminated
Page 29 - PLAN OF DISTRIBUTION
Page 30 - Underwriters.
Page 31 - Passive Market Making.
Page 32 - INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
Page 33 - PART II
Page 34 - ITEM 16. Exhibits
Page 35 - ITEM 17. Undertakings
Page 36 - N/A
Page 37 - N/A
Page 38 - INDEX TO EXHIBITS
Page 39 - SIGNATURES
Page 40 - N/A
Subdocument 2 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - Certificate of Incorporation
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Subdocument 3 - EX-12.1 - EX-12.1
Page 1 - Exhibit 12.1
Page 2 - N/A
Subdocument 4 - EX-23.1 - EX-23.1
Page 1 - Exhibit 23.1
Page 2 - N/A
Subdocument 5 - EX-25.1 - EX-25.1
Page 1 - Exhibit 25.1
Page 2 - General Information.
Page 3 - SIGNATURE
Page 4 - EXHIBIT 6
Page 5 - Exhibit 7
Page 6 - N/A
Page 7 - N/A